Skip to main content
Log in

Evidence for separate diseases?

Stages of one disease or different combinations of symptom dimensions?

  • STUDY BASED DISCUSSION
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Objective

We tested Kraepelin’s dichotomy model by studying the separability of schizophrenia and depression on the basis of symptoms and illness course.

Materials and methods

Matched untreated patients with schizophrenia and depression (n = 130 each) and 130 “healthy” controls were assessed from onset to first admission. In a second study the same variables were studied in 107 patients with schizophrenia over a homogenised follow-up of 134 months (11.2 years).

Results

The symptom most frequently marking the onset of both schizophrenia and depression was depressive mood. Both disorders exhibited the same prodromal core syndrome. It was not until the emergence of positive symptoms that the disorders became separable by the international classification systems. Depression remained the most frequent syndrome over the entire course of schizophrenia.

Conclusion

Depression does not represent comorbidity, but an integral part of psychosis. A dimensional disease model based on successively emerging hierarchical symptom patterns, not unknown to the later Kraepelin, is offered as an explanation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Achard S, Salvador R, Whitcher B, Suckling J, Bullmore E (2006) A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci 26:63–72

    Article  PubMed  CAS  Google Scholar 

  2. Addington D, Addington J, Patten S (1998) Depression in people with first-episode schizophrenia. Br J Psychiatry 172:90–92

    CAS  Google Scholar 

  3. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh- Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA (2004) Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420:21–27

    PubMed  Google Scholar 

  4. Andreasen NC (1983) The scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City

    Google Scholar 

  5. Angst J (1980) Verlauf unipolar depressiver, bipolar manisch-depressiver und schizo-affektiver Erkrankungen und Psychosen. Ergebnisse einer prospektiven Studie. Fortschr Neurol Psychiatr Grenzgeb 48:3–30

    CAS  Google Scholar 

  6. Angst J, Scharfetter C, Stassen HH (1983) Classification of schizo-affective patients by multidimensional scaling and cluster analysis. Psychiatr Clin 16:254–264

    CAS  Google Scholar 

  7. Biehl H, Maurer K, Jablensky A, Cooper JE, Tomov T (1989) The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept. Br J Psychiatry 155(Suppl. 7):68–70

    Google Scholar 

  8. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC (2001) Duration of untreated psychosis predicts treatment outcome in early psychosis program. Schizophr Res 47:215–222

    Article  PubMed  CAS  Google Scholar 

  9. Breier A, Schreiber JL, Dyer J, Pickar D (1991) National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 48:239–246

    PubMed  CAS  Google Scholar 

  10. Bressan RA, Chaves AC, Pilowsky LS, Shirakawa I, Mari JJ (2003) Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Res 117:47–56

    Article  PubMed  Google Scholar 

  11. der an Heiden W, Krumm B, Müller S, Weber I, Biehl H, Schäfer M (1995) Mannheimer Langzeitstudie der Schizophrenie. Nervenarzt 66:820–827

    Google Scholar 

  12. der an Heiden W, Könnecke R, Maurer K, Ropeter D, Häfner H (2005) Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 255:174–184

    Article  Google Scholar 

  13. Goldberg TE, David A, Gold JM (2003) Neurocognitive deficits in schizophrenia. In: Hirsch SR, Weinberger D (eds) Schizophrenia. 2nd edn. Blackwell, Oxford, pp 168–184

    Google Scholar 

  14. Häfner H, an der Heiden W (2003) Course and outcome of schizophrenia. In: Hirsch SR, Weinberger DR (eds) Schizophrenia, 2nd edn. Blackwell, Oxford, pp 101–141

    Google Scholar 

  15. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6:209–223

    Article  PubMed  Google Scholar 

  16. Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162:80–86

    PubMed  Google Scholar 

  17. Häfner H, Maurer K, Löffler W, an der Heiden W, Munk-Jφrgensen P, Hambrecht M, Riecher-Rössler A (1998a) The ABC schizophrenia study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 33:380–386

    Article  PubMed  Google Scholar 

  18. Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, Maurer K, Munk-Jørgensen P, Nowotny B, Riecher-Rössler A, Stein A (1998b) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 24:99–113

    PubMed  Google Scholar 

  19. Häfner H, Maurer K, Löffler W, an der Heiden W, Stein A, Könnecke R, Hambrecht M (1999a) Onset and prodromal phase as determinants of the course. In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, vol. IV: balance of the century. Steinkopff, Darmstadt, pp 35–58

    Google Scholar 

  20. Häfner H, Löffler W, Maurer K, Riecher-RösslerA, Stein A (1999b) IRAOS. Interview für die retrospektive Erfassung des Erkrankungsbeginns und –verlaufs bei Schizophrenie und anderen Psychosen. Hans Huber Verlag, Bern

    Google Scholar 

  21. Häfner H, Löffler W, Maurer K, Riecher-Rössler A, Stein A (2003) IRAOS—Interview for the retrospective assessment of the onset and course of schizophrenia and other psychoses. Hogrefe & Huber, Göttingen

    Google Scholar 

  22. Häfner H, Maurer K, Ruhrmann S, Bechdolf S, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller H-J, Gaebel W, Wölwer W (2004) Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 254:117–128

    Article  PubMed  Google Scholar 

  23. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Könnecke R (2005) Schizophrenia and depression: challenging the paradigm of two separate diseases -a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 77:11–24

    Article  PubMed  Google Scholar 

  24. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PWH, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen PW, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma Y (2001) Recovery from psychotic illness: a 15 and 25 year international follow-up study. Br J Psychiatry 178:506–517

    Article  PubMed  CAS  Google Scholar 

  25. Jackson H (1887) Remarks on evolution and dissolution of the nervous system. J Ment Sci 33:25–48

    Google Scholar 

  26. Jung E, Krumm B, Biehl H, Maurer K, Bauer-Schubart C (1989) Mannheimer Skala zur Einschätzung von sozialer Behinderung (DAS-M). Beltz, Weinheim

    Google Scholar 

  27. Kahlbaum KL (1874) Die Katatonie oder das Spannungsirresein. Hirschwald, Berlin

    Google Scholar 

  28. Kendell RE, Brockington IF (1980) The identification of disease entities and the relationship between schizophrenic and affective psychoses. Br J Psychiatry 137:324–331

    PubMed  CAS  Google Scholar 

  29. Köhn D, Niedersteberg A, Wieneke A, Bechdolf A, Pukrop R, Ruhrmann S, Schultze-Lutter F, Maier W, Kloskterkötter J (2003) Frühverlauf schizophrener Ersterkrankungen mit langer Dauer der unbehandelten Erkrankung – eine vergleichende Studie. Fortschr Neurol Psychiatr 71:1–5

    Article  Google Scholar 

  30. Kraepelin E (1896) Psychiatrie, 5th edn. Barth, Leipzig

    Google Scholar 

  31. Kraepelin E (1904) Psychiatrie, Bd 2: Klinische Psychiatrie, 7. Aufl. Barth, Leipzig

    Google Scholar 

  32. Kraepelin E (1920) Die Erscheinungsformen des Irreseins. Zschr Ges Neurol Psychiat 62:1–29

    Article  Google Scholar 

  33. Maier W (2006) Do schizoaffective disorders exist at all? Acta Psychiatr Scand 113:369–371

    Article  PubMed  Google Scholar 

  34. Manchanda R, Norman A, Malla R, Harricharan S Northcott S (2005) Persistent psychoses in first episode patients. Schizophr Res 80: 113–116

    Article  PubMed  Google Scholar 

  35. Marneros A, Deister A, Rohde A, Steinmeyer EM, Jünemann H (1989a) Long-term outcome of schizoaffective and schizophrenic disorders: A comparative study. Part I: definitions, methods, psychopathological and social outcome. Eur Arch Psychiatry Neurol Sci 238:118–125

    Article  PubMed  CAS  Google Scholar 

  36. Marneros A, Steinmeyer EM, Deister A, Rohde A, Jünemann H (1989b) Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III: Social consequences. Eur Arch Psychiatry Neurol Sci 238:135–139

    Article  PubMed  CAS  Google Scholar 

  37. Marneros A, Deister A, Rohde A (1991) Affektive, schizoaffektive und schizophrene Psychosen. Springer, Berlin

    Google Scholar 

  38. Maurer K, Trendler G, Schmidt M, an der Heiden W, Könnecke R, Häfner H (2006) Schizophrenie und depression. Nervenarzt 77:809–822

    Article  PubMed  CAS  Google Scholar 

  39. Möller H-J (2005) Antipsychotic and antidepressive effects of second generation antipsychotics. Eur Arch Psychiatry Clin Neurosci (Special Issue) 255:190–201

    Article  Google Scholar 

  40. Möller H-J, v Zerssen D (1986) Der Verlauf schizophrener Psychosen unter den gegenwärtigen Behandlungsbedingungen. Springer, Berlin

    Google Scholar 

  41. Riedel O, Dodel R, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenckwalder C, Wittchen H-U (2006) Wie beurteilen Ärzte die HÄufigkeit demenzieller, depressiver und psychotischer Symptome bei Patienten mit der Parkinson-Krankheit? Eine Befragung von 500 FachÄrzten im ambulanten Versorgungssektor Deutschlands. Akt Neurol 33:374–380

    Article  Google Scholar 

  42. Schulze TG, Ohlraum S, Czerski PM, Schumacher J, Kassem I, Deschner M, Gross M, Tullius M, Heidman V, Kovalenko S, Jamra RA, Becker T, Leszcynska-Rodziewicz A, Hauser J, Illig T, Klopp N, Wellek S, Chichon S, Henn FA, McMahon FJ, Maier W, Propping P, Nothen MM, Rietschel M (2005) Genotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 162:2101–2108

    Article  PubMed  Google Scholar 

  43. Selten J-P, Veen N, Feller W, Blom JD, Kahn R, Schols D, Camoenië W, Oolders J, van der Velden M, Hoek HW, Vladár-Rivero VR, van der Graaf Y (2001) Incidence of psychotic disorders in immigrant groups to the Netherlands. Br J Psychiatry 178:367–372

    Article  PubMed  CAS  Google Scholar 

  44. Stefanis N, Hanssen M, Smirnis N, Avramopoulos D, Evdokimidis I, Stefanis CN, Verdoux H, van Os J (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 32:347–358

    Article  PubMed  CAS  Google Scholar 

  45. Sydenham T (1742) Observationes medicare (1676). In: Swan J (eds) The entire works of Thomas Sydenham, newly made English from the originals. Cave, London

    Google Scholar 

  46. Tsuang MT, Fleming JA (1987) Long-term outcome of schizophrenia and other psychoses. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin, pp 88–97

    Google Scholar 

  47. Van Os J, Verdoux H, Maurice-Tison S, Gay B, Liraud F, Salamon R, Bourgeois M (1999) Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol 34:459–463

    Article  PubMed  Google Scholar 

  48. Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, an der Heiden W, Nienhuis FJ, Walsh D (2000) Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 30:1155–1167

    Article  PubMed  CAS  Google Scholar 

  49. Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms: an instruction manual for the PSE and CATEGO Program. Cambridge University Press, London

    Google Scholar 

  50. Wittchen H-U, Höfler M, Lieb R, Spauwen J, van Os J (2004) Depressive und psychotische Symptome in der Bevölkerung – Eine prospektiv-longitudinale Studie (EDSP) an 2.500 Jugendlichen und jungen Erwachsenen. Paper presented at the DGPPN Congress, Berlin, 24–27 Nov 2004 (Abstract published in Nervenarzt 75: Suppl. 2:87)

  51. World Health Organization (1988) Psychiatric disability assessment Schedule, Geneva, WHO

Download references

Disclosure

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heinz Häfner.

Additional information

Paper presented at the Letten Foundation symposium “Emil Kraepelin’s dichotomy—was it true? Kraepelin’s contribution to psychiatry”, commemorating Kraepelin’s 150 birthday—30 April 2007, Munich

Rights and permissions

Reprints and permissions

About this article

Cite this article

Häfner, H., an der Heiden, W. & Maurer, K. Evidence for separate diseases?. Eur Arch Psychiatry Clin Neurosc 258 (Suppl 2), 85–96 (2008). https://doi.org/10.1007/s00406-008-2011-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-008-2011-4

Key words

Navigation